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Abstract
Thyroid nodules are encountered in clinical practice during the diagnostic procedures or patients’ follow-up due to other dis-
eases quite far from the thyroid gland with prevalence 4–50% in general population, depending on age, diagnostic method and 
race. The prevalence of thyroid nodules increases with age and their clarification should be done for their adequate treatment. 
An 18F-FDG PET/CT was done with a PET/CT scanner (Philips Gemini TF), consisting of dedicated lutetium orthosilicate full 
ring PET scanner and 16 slice CT.
The PET/CT scan of the whole-body revealed on the CT portion a hypodense nodular lesion in the left lobe of the thyroid gland 
with increased uptake of 18F-FDG on the PET with SUVmax 10.3 and demonstrated a complete response to the induction therapy 
of the main oncological disease of the patient — squamous cell carcinoma. 
This clinical case demonstrates that whole-body 18F-FDG-PET/CT has an increasingly important role in the early evaluation of 
thyroid cancer as a second independent malignant localization. Focal thyroid lesion with high risk of thyroid malignancy was 
incidentally found on 18F-FDG PET/CT.
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Introduction
Asymptomatic thyroid nodules are often encountered in 
clinical practice and its prevalence is 4–50% in general population 
depending on age, diagnostic methods and race. The prevalence 
of thyroid nodules increases with age. Thyroid incidentalomas are 
characterized as focal not palpable intrathyroidal new nodular le-
sions detected by imaging modalities during study for non-thyroidal 
disease. These nodules are usually not palpable and benign, with 
an associated risk of cancer ranging from 1.5–10% [1, 2]. 
Positron emission tomography (PET/CT) using 18F-fluorodeox-
yglucose (FDG) is increasingly performed for staging and for exact 
localization of metastatic disease in patients with various kinds of 
malignancies [2–5]. The FDG PET/CT provides the advantages of 
the two modalities; the anatomic information is provided by the 
spiral CT and the functional information by the FDG PET. This com-
bined approach has resulted in a significant improvement in both 
anatomic localization and diagnostic accuracy [6, 7].
The uptake of FDG in the normal thyroid gland is usually not 
visualized on FDG-PET [8, 9]. 
Focal or diffuse FDG uptake in the thyroid gland could be 
seen as an incidental finding. Some studies have reported that the 
incidence of thyroid incidentalomas with increased FDG uptake 
is 1.2–2.3% on PET examinations [7, 8, 10, 11]. 
Subject of our study was to evaluate treatment response 
with a whole-body 18F-FDG PET/CT in a 61 year old female with 
squamous cell cervix carcinoma, pT2pN1M0. After the induction 
therapy, radical laparohysterectomy with colpo-urethro-cystectomy, 
lymphadenectomy bilateral in the pelvis, para-aortal and presacral 
lymph nodes, chemotherapy and radiotherapy were performed. 
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The whole-body 18F-FDG PET/CT images ware done applying 
a PET/CT scanner (Philips Gemini TF), consisting of dedicated lu-
tetium orthosilicate full ring PET scanner and 16 slice CT. Standard 
patient preparation included at least 6 hours fasting and serum 
glucose level of less than 120 mg/dl before 18F-FDG administration. 
PET/CT imaging was performed 60 minute after intravenous injec-
tion of 370 MBq (10 mCi) of 18F-FDG.
At 60 minute after administration of 18F-FDG, low dose 
CT (50 mAs, 120 kV) covering area from scull to the proximal 
thighs was performed for the purpose of attenuation correction 
and precise anatomical localization. Thereafter, emission scan 
was conducted in the three-dimensional mode. Emission scan 
time per mm was 39 mm/sec. PET data were obtained using 
a high-resolution whole-body scanner with an axial field of view of 
57.6 cm. The average total PET/CT examination time was 20 min-
utes. Standardized uptake value (SUVmax) was estimated for every 
hypermetabolic lesion.
After scatter and decay correction, PET data were recon-
structed iteratively with attenuation correction and they were 
reoriented in axial, sagittal, and coronal slices. The row action 
maximum-likelihood algorithm was used for three dimensional 
reconstructions.
Discussion
The PET/CT whole-body scan revealed loco-regional complete 
therapeutic response of the squamous cell cervix carcinoma (Figure 1) 
and a hypodense nodular lesion in the left lobe of the thyroid gland 
with increased uptake of 18F-FDG with SUVmax 10.3 (Figure 2A–C). 
After the PET/CT scan of the whole body, fine needle aspiration 
biopsy (FNAB) was performed of the left lobe of the thyroid gland 
nodular lesion under ultrasound (US) control.
The result of the biopsy showed a thyroid tumor with lobular 
pattern. The stroma of the tumor is composed of fibrovascular 
tissue. Tumor cells are polygonal or slightly spindled without 
conspicuous nucleoli and with granular chromatin. ICH-positive 
immunoreactivity for synaptophysin and TTF1. 
Patient underwent thyroidectomy. Histopathological diagno-
sis was — medullary carcinoma of thyroid (Figure 3). After the sur-
gery the thyrocalcitonin was normal but during the patient follow-up 
increased and in the sixth month reached 1832 pg/ml (ref. 0–13) 
and a control whole-body 18F-PET/CT was done.
Figure 1. Physiologic uptake of the 18F-FDG-PET true-out the body in 
the heart, right kidney after the surgery and hypermetabolic increased 
uptake of the 18F-FDG in the left anterior part of the neck base
Figure 2A–C. Transaxial scan of the CT, PET and PET/CT.  
A. Hypodense nodular lesion in the left lobe of the thyroid gland 
(white arrow); B. Hypermetabolic increased uptake of the 18F-FDG in 
the level of the left-anterior part of the base of the neck without exact 
anatomical localization; C. Focal FDG uptake with exact anatomical 
localization in the left lobe of the thyroid gland on PET/CT (white 
arrow). Histopathological data after a FNAB under an US control 
verified medullar thyroid carcinoma
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On the 18F-FDG-PET hypermetabolic multiple pulmonary, bone 
and soft tissue metastases were visualized (Figure 4). PET/CT 
demonstrated a progression of the medullary carcinoma disease 
with the whole body aggressive metastatic involvement.
Conclusion
The current widespread usage of whole-body 18F-FDG 
PET/CT studies as a screening tool for evaluation of malignant 
tumors has resulted in an increase in the detection of incidentally 
found thyroid lesions. 
In fact, as this technology becomes more available, the inci-
dence of thyroid incidentalomas will likely continue to increase. 
Focal thyroid lesions incidentally found on 18F-FDG PET/CT have 
high risk of thyroid malignancies.
Whole-body 18F-FDG PET/CT is playing an increasingly impor-
tant role in the evaluation of asymptomatic thyroid cancer. 
Figure 3. Fine needle aspiration biopsy — ICH-positive immunoreactivity 
for synaptophysin and TTF1. Diagnosis — medullary carcinoma of 
thyroid
Figure 4. 18F-FDG PET/CT whole-body scan displays multiple pulmonary, bone and soft tissue metastases and a disease progression
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